Search Results

LY2109761 100mg 100mg  | Purity Not Available

Adooq Bioscience

LY2109761, a novel transforming growth factor ?? receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis

More Information Supplier Page

LY2109761 10mg 10mg  | Purity Not Available

Adooq Bioscience

LY2109761, a novel transforming growth factor ?? receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis

More Information Supplier Page

INCB28060 50mg 50mg  | Purity Not Available

Adooq Bioscience

INCB28060, a novel inhibitor of c-MET kinase. INCB28060 exhibits picomolar enzymatic potency and is highly specific for c-MET with more than 10,000-fold selectivity over a large panel of human kinases. This inhibitor potently blocks c-MET phosphorylation and activation of its key downstream effectors in c-MET-dependent tumor cell lines.

More Information Supplier Page

INCB28060 5mg 5mg  | Purity Not Available

Adooq Bioscience

INCB28060, a novel inhibitor of c-MET kinase. INCB28060 exhibits picomolar enzymatic potency and is highly specific for c-MET with more than 10,000-fold selectivity over a large panel of human kinases. This inhibitor potently blocks c-MET phosphorylation and activation of its key downstream effectors in c-MET-dependent tumor cell lines.

More Information Supplier Page

INCB28060 25mg 25mg  | Purity Not Available

Adooq Bioscience

INCB28060, a novel inhibitor of c-MET kinase. INCB28060 exhibits picomolar enzymatic potency and is highly specific for c-MET with more than 10,000-fold selectivity over a large panel of human kinases. This inhibitor potently blocks c-MET phosphorylation and activation of its key downstream effectors in c-MET-dependent tumor cell lines.

More Information Supplier Page